Welcome to LookChem.com Sign In|Join Free
  • or
1-(3-ethoxy-4-methoxy-benzyl)-piperidin-4-ylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

951004-04-9

Post Buying Request

951004-04-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

951004-04-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 951004-04-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,0,0 and 4 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 951004-04:
(8*9)+(7*5)+(6*1)+(5*0)+(4*0)+(3*4)+(2*0)+(1*4)=129
129 % 10 = 9
So 951004-04-9 is a valid CAS Registry Number.

951004-04-9Downstream Products

951004-04-9Relevant academic research and scientific papers

PHENYL, PYRIDINE, QUINOLINE, ISOQUINOLINE, NAPHTHYRIDINE AND PYRAZINE DERIVATIVES

-

, (2008/06/13)

This invention is concerned with compounds of the formulaand pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

PYRIMIDINE AND QUINAZOLINE DERIVATIVES

-

Page/Page column 46, (2008/06/13)

This invention is concerned with compounds of the formula ( l ) wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

Pyrimidine, quinazoline, pteridine and triazine derivatives

-

Page/Page column 25, (2008/06/13)

This invention is concerned with compounds of the formula wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 951004-04-9